Document:

EX-10.23

 Exhibit 10.23 

INCENTIVE STOCK OPTION 

Granted by 
 Applied Genetic
Technologies Corporation (the “Company”) 
 Under the 2013 Equity and Incentive Plan 

This Option is and shall be subject in every respect to the provisions of the Company’s 2013 Equity and Incentive Plan, as amended from
time to time (the “Plan”), which is incorporated herein by reference and made a part hereof. The holder of this Option (the “Holder”) hereby accepts this Option subject to all the terms and provisions of the Plan and agrees that
(a) in the event of any conflict between the terms hereof and those of the Plan, the latter shall prevail, and (b) all decisions under and interpretations of the Plan by the Board or the Committee shall be final, binding and conclusive
upon the Holder and his or her heirs and legal representatives. 
  

	1.	 Name of Holder: 

 

	2.	 Date of Grant: 

 

	3.	 Vesting Start Date:  

 

	4.	 Maximum number of shares for which this Option is exercisable: 

 

	5.	 Exercise (purchase) price per share:  

 

	6.	 Method of Exercise. This Option may be exercised by the delivery of written notice to the Company
setting forth the number of shares with respect to which the Option is to be exercised, together with payment by one of the following methods: 

cash, or certified or bank check or other instrument acceptable to the Administrator for an amount equal to the exercise price of the shares
being purchased; or 
 any of the other methods set forth in the Plan. 

 

	7.	 Expiration Date of Option:  

 

	8.	 Vesting Schedule: 

 

	9.	 Termination of Employment. This Option shall terminate on the earliest to occur of:

  

	 	(i)	 the date of expiration hereof; 

 

	 	(ii)	 three (3) months following the Termination Date upon any termination other than for Disability or death;
or 

	 	(ii)	 twelve (12) months following the Termination Date upon termination for Disability or death, or if the
Holder dies within three (3) months after his or her Termination Date 

  

	10.	 Incentive Stock Option; Disqualifying Disposition. Although this Option is intended to qualify as an
incentive stock option under the Internal Revenue Code of 1986 (the “Code”), the Company makes no representation as to the tax treatment upon exercise of this Option or sale or other disposition of the shares covered by this Option, and
the Holder is advised to consult a personal tax advisor. Upon a Disqualifying Disposition of shares received upon exercise of this Option, the Holder will forfeit the favorable income tax treatment otherwise available with respect to the exercise of
this Option. A “Disqualifying Disposition” shall have the meaning specified in Section 421(b) of the Code; as of the date of grant of this Option a Disqualifying Disposition is any disposition (including any sale) of such shares
before the later of (a) the second anniversary of the date of grant of this Option and (b) the first anniversary of the date on which the Holder acquired such shares by exercising this Option, provided that such holding
period requirements terminate upon the death of the Holder. The Holder shall notify the Company in writing immediately upon making a Disqualifying Disposition of any shares of Common Stock received pursuant to the exercise of this Option, and shall
provide the Company with any information that the Company shall request concerning any such Disqualifying Disposition. 

  

	11.	 Notice. Any notice to be given to the Company hereunder shall be deemed sufficient if addressed to the
Company and delivered to the office of the Company, Applied Genetic Technologies Corporation, 14193 NW 119th Terrace, Suite 10, Alachua, FL 32615, attention of the President and CEO, or such other address as the Company may hereafter designate.

 Any notice to be given to the Holder hereunder shall be deemed sufficient if addressed to and delivered in person to the
Holder at his or her address furnished to the Company or when deposited in the mail, postage prepaid, addressed to the Holder at such address. 

IN WITNESS WHEREOF, the parties have executed this Option, or caused this Option to be executed, as of the Date of Grant. 

 

			
	Applied Genetic Technologies Corporation
		
	By:	 	  

 The undersigned Holder hereby acknowledges receipt of a copy of the Plan and this Option, and agrees to the terms of
this Option and the Plan. 
  

	
	  

	Holder

  
 2EX-10.24

 Exhibit 10.24 

NONSTATUTORY STOCK OPTION 

Granted by 
 Applied Genetic
Technologies Corporation (the “Company”) 
 Under the 2013 Equity and Incentive Plan 

This Option is and shall be subject in every respect to the provisions of the Company’s 2013 Equity and Incentive Plan, as amended from
time to time (the “Plan”), which is incorporated herein by reference and made a part hereof. The holder of this Option (the “Holder”) hereby accepts this Option subject to all the terms and provisions of the Plan and agrees that
(a) in the event of any conflict between the terms hereof and those of the Plan, the latter shall prevail, and (b) all decisions under and interpretations of the Plan by the Board or the Committee shall be final, binding and conclusive
upon the Holder and his or her heirs and legal representatives. 
  

	1.	 Name of Holder: 

 

	2.	 Date of Grant: 

 

	3.	 Vesting Start Date:  

 

	4.	 Maximum number of shares for 

	 	which	 this Option is exercisable: 

 

	5.	 Exercise (purchase) price per share:  

 

	6.	 Method of Exercise. This Option may be exercised by the delivery of written notice to the Company
setting forth the number of shares with respect to which the Option is to be exercised, together with payment by one of the following methods: 

cash, or certified or bank check or other instrument acceptable to the Administrator for an amount equal to the exercise price of the shares
being purchased; or 
 any of the other methods set forth in the Plan. 

 

	7.	 Expiration Date of Option:  

 

	8.	 Vesting Schedule: 

 

	9.	 Termination of Services. This Option shall terminate on the earliest to occur of: 

 

	 	(i)	 the date of expiration hereof; 

 

	 	(ii)	 three (3) months following the Termination Date upon any termination other than for Disability or death;
or 

	 	(ii)	 twelve (12) months following the Termination Date upon termination for Disability or death, or if the
Holder dies within three (3) months after his or her Termination Date 

  

	10.	 Tax Withholding. The Company’s obligation to deliver shares shall be subject to the Holder’s
satisfaction of any federal, state and local income and employment tax withholding requirements 

  

	11.	 Notice. Any notice to be given to the Company hereunder shall be deemed sufficient if addressed to the
Company and delivered to the office of the Company, Applied Genetic Technologies Corporation, 14193 NW 119th Terrace, Suite 10, Alachua, FL 32615, attention of the President and CEO, or such other address as the Company may hereafter designate.

 Any notice to be given to the Holder hereunder shall be deemed sufficient if addressed to and delivered in person to the
Holder at his or her address furnished to the Company or when deposited in the mail, postage prepaid, addressed to the Holder at such address. 

IN WITNESS WHEREOF, the parties have executed this Option, or caused this Option to be executed, as of the Date of Grant. 

 

			
	Applied Genetic Technologies Corporation
		
	By:	 	  

 The undersigned Holder hereby acknowledges receipt of a copy of the Plan and this Option, and agrees to the terms of
this Option and the Plan. 
  

	
	  

	Holder

  
 2EX-10.25

 Exhibit 10.25 

RESTRICTED STOCK UNIT AGREEMENT 

Granted by 
 Applied Genetic
Technologies Corporation 
 Under the 2013 Equity and Incentive Plan 

Applied Genetic Technologies Corporation (the “Company”) hereby grants to the person named below (the “Recipient”)
restricted stock units (“Restricted Stock Units”), with each such unit representing the right to receive one share of Stock, pursuant to the terms set forth below (the “Award”). The Award is and shall be subject in every respect
to the provisions of the Company’s 2013 Equity and Incentive Plan, as amended from time to time (the “Plan”), which is incorporated herein by reference and made a part hereof. The Recipient hereby accepts this Award subject to all the
terms and provisions of the Plan and agrees that (a) in the event of any conflict between the terms hereof and those of the Plan, the latter shall prevail, and (b) all decisions under and interpretations of the Plan by the Board or the
Committee shall be final, binding and conclusive upon the Recipient and his or her heirs and legal representatives. Capitalized terms used herein but not defined shall have the meaning set forth in the Plan. 

 

	1.	 Name of Recipient:  

 

	2.	 Date of Grant:  

 

	3.	 Maximum Number of Restricted Stock Units: 

 

	4.	 Vesting of Restricted Stock Units: 

 

	5.	 Payment. Upon each vesting date, the Recipient shall receive one share of Stock for each vested
Restricted Stock Unit; provided, however, that the number of shares issued shall be reduced by the number of shares sufficient to satisfy the minimum tax withholding obligations as set forth in Section 6 below. 

 

	6.	 Withholding. Upon the settlement of Restricted Stock Units pursuant to Section 5 above, the Company
shall withhold from issuance a number of shares sufficient to satisfy the minimum Federal, state, local and/or payroll taxes of any kind required by law to be withheld with regard to such settlement. 

 

	7.	 No Rights to Shares or as a Stockholder. The Recipient shall not have any right in, or with respect to,
any of the shares of Stock issuable under the Award (including voting rights) unless and until the Award vests and is settled by issuance of the shares to the Recipient. 

 

	8.	 Nontransferability. The Restricted Stock Units are personal to the Recipient and shall not be
transferable or assignable, other than by will or the laws of descent and distribution, and any such purported transfer or assignment shall be null and void. 

	9.	 Termination of Employment. If the Recipient’s employment with or service for the Company is
terminated, for any reason or no reason, with or without cause, all unvested Restricted Stock Units shall immediately terminate and be of no further force or effect. 

 

	10.	 Notice. Any notice to be given to the Company hereunder shall be deemed sufficient if addressed to the
Company and delivered to the office of the Company, Applied Genetic Technologies Corporation, 14193 NW 119th Terrace, Alachua, FL 32615, attention of the chief financial officer, or such other
address as the Company may hereafter designate. 

 Any notice to be given to the Recipient hereunder shall be deemed
sufficient if addressed to and delivered in person to the Recipient at his or her address furnished to the Company or when deposited in the mail, postage prepaid, addressed to the Recipient at such address. 

  
 2 

 IN WITNESS WHEREOF, the parties have executed this Award, or caused this Award to be
executed, as of the Date of Grant. 
  

			
	Applied Genetic Technologies Corporation

 
			
		
	By:	 	  

 The undersigned Recipient hereby acknowledges receipt of a copy of the Plan and this Award, and agrees to the terms of
this Award and the Plan. 
  

	
	  

	[Name of Recipient]

  
 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}]]